Mutual Fund Details
NAV
₹30.6930
as on 08 Dec 2023, 09:00 PM
₹-0.1620(0.53%)
Last Change
Scheme Ratings
1
Pharma
5Y Returns
Pharma
Rankings based on 5Y Returns | as on 12 Dec 2023
×
1
DSP Healthcare Fund Direct - Growth
25.24%
2
Mirae Asset Healthcare Fund Direct - Growth
23.88%
3
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
22.96%
4
Tata India Pharma & HealthCare Fund Direct-Growth
22.14%
5
Nippon India Pharma Fund Direct-Growth
21.46%
Schemes Managed By
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹1,50,935
₹1,57,399
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹57,400
Profit (absolute return)
57.40%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
9.30%
In the last 6 months
25.88%
In the last 1 year
29.67%
In the last 3 years
57.40%
In the last 5 years
208.44%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
DSP Healthcare Fund Direct - Growth
as of 31 Oct 2023, 05:30 AM
₹1,717.54 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 0.50% if redeemed within 1 month.
0.71%
Expense Ratio
Plan
Growth
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Scheme Document
Companies Holding in this Mutual Fund
as on 31 Oct 2023
Sun Pharmaceutical Inds. Ltd.
12.91%
₹221.73 Cr
Ipca Laboratories Ltd.
8.69%
₹149.25 Cr
Cipla Ltd.
8.42%
₹144.62 Cr
Suven Pharmaceutical Ltd.
7.81%
₹134.14 Cr
Lupin Ltd.
7.18%
₹123.32 Cr
Others
54.99%
₹944.48 Cr
View All
View All
This fund's returns:
16.32%Return Duration
3 Years
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
9.02%
16.35%
3Y Returns
16.35
Nippon India Pharma Fund Direct-Growth
EquityPharma
Min. Investment
₹100
Category Returns
9.02%
16.35%
3Y Returns
16.25
Tata India Pharma & HealthCare Fund Direct-Growth
EquityPharma
Min. Investment
₹150
Category Returns
9.02%
16.35%
3Y Returns
15.88
About DSP Healthcare Fund Direct - Growth
DSP Healthcare Fund Direct - Growth is a Equity mutual fund scheme from DSP Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Chirag Dagli. It has an AUM of ₹1,717.54 Crores and the latest NAV decalared is ₹30.693 as on 12 Dec 2023 at 1:02 am.
DSP Healthcare Fund Direct - Growth scheme return performance in last 1 year is 29.67%, in last 3 years is 57.40% and 205.28% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
| AUM: | ₹1,717.54 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
DSP Mutual Fund
View AMC Details
₹1,29,575.42 Cr
AUM
135
Schemes
Address
NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road JunctionWestern Express Highway,Andheri East400069
Phone Number
Phone : 1800-208-4499 / 1800-200-4499
Fax : 022-56578181
Email / Website
Start investing in minutes
Download app to Explore
Scan this QR code to download the app now!
Or download from
